Lv4
580 积分 2023-10-22 加入
NUF2 activated by YY1 promotes prostate cancer malignancy via p38/MAPK signaling axis and serves as a therapeutic target
5个月前
已完结
Current therapy and drug resistance in metastatic castration-resistant prostate cancer
5个月前
已完结
PSMA-based Therapies and Novel Therapies in Advanced Prostate Cancer: The Now and the Future
9个月前
已完结
Advances in PSMA-Targeted Radionuclide Therapeutics
9个月前
已完结
PSMA Radiotheranostics in Prostate Cancer: Principles, Practice, and Future Prospects
9个月前
已完结
Advances in the treatment of metastatic prostate cancer
9个月前
已完结
177Lu-PSMA therapy in metastatic prostate cancer: An updated review of prognostic and predictive biomarkers
9个月前
已完结
Novel radionuclide therapy combinations in prostate cancer
9个月前
已完结
Novel radionuclide therapy combinations in prostate cancer
9个月前
已完结
皖公网安备34019202002308
